Total Payments
$8,347
2024 Payments
$83.68
Companies
51
Transactions
353
Payment Breakdown by Category
Food & Beverage$7,666 (91.8%)
Education$681.42 (8.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,666 | 344 | 91.8% |
| Education | $681.42 | 9 | 8.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,103 | 50 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $568.94 | 24 | $0 (2023) |
| Celgene Corporation | $530.79 | 24 | $0 (2023) |
| Incyte Corporation | $511.24 | 21 | $0 (2023) |
| Janssen Biotech, Inc. | $482.50 | 14 | $0 (2023) |
| Astellas Pharma US Inc | $388.68 | 12 | $0 (2023) |
| Merck Sharp & Dohme LLC | $376.19 | 17 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $368.97 | 13 | $0 (2023) |
| Amgen Inc. | $301.54 | 11 | $0 (2023) |
| Eisai Inc. | $298.78 | 18 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $83.68 | 3 | Stemline Therapeutics Inc. ($30.00) |
| 2023 | $3,978 | 170 | Novartis Pharmaceuticals Corporation ($588.58) |
| 2022 | $3,934 | 167 | Novartis Pharmaceuticals Corporation ($495.92) |
| 2021 | $351.27 | 13 | Janssen Biotech, Inc. ($77.99) |
All Payment Transactions
353 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/10/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $29.51 | General |
| Category: General - Pain Management_NMD | ||||||
| 06/28/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: Oncology | ||||||
| 12/05/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.20 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2023 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $29.13 | General |
| Category: ONCOLOGY | ||||||
| 11/16/2023 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $27.92 | General |
| Category: Oncology | ||||||
| 11/14/2023 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $27.12 | General |
| Category: Oncology | ||||||
| 11/14/2023 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $21.42 | General |
| Category: Hematology | ||||||
| 11/13/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $28.15 | General |
| Category: Oncology | ||||||
| 11/08/2023 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: Oncology | ||||||
| 11/02/2023 | PFIZER INC. | BOSULIF (Drug), BESPONSA, ELREXFIO | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 11/02/2023 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Oncology | ||||||
| 11/01/2023 | Astellas Pharma US Inc | Xospata (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Oncology | ||||||
| 10/26/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $31.52 | General |
| Category: Oncology | ||||||
| 10/26/2023 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $25.69 | General |
| Category: Oncology | ||||||
| 10/23/2023 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: HEMATOLOGY | ||||||
| 10/21/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $5.72 | General |
| Category: Oncology | ||||||
| 10/19/2023 | Amneal Pharmaceuticals LLC | AVASTIN (Drug), NEULASTA, NEUPOGEN | Food and Beverage | In-kind items and services | $27.89 | General |
| Category: ONCOLOGY | ||||||
| 10/19/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: ONCOLOGY | ||||||
| 10/18/2023 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2023 | ImmunoGen, Inc. | Elahere (Biological) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Oncology | ||||||
| 10/17/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.28 | General |
| 10/17/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $6.01 | General |
| Category: Oncology | ||||||
| 10/15/2023 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug), Vitrakvi | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: Oncology | ||||||
| 10/13/2023 | Agios Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $22.32 | General |
About Alexander Lee, FNP
Alexander Lee, FNP is a Family healthcare provider based in Newport Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/28/2020. The National Provider Identifier (NPI) number assigned to this provider is 1770190340.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Alexander Lee, FNP has received a total of $8,347 in payments from pharmaceutical and medical device companies, with $83.68 received in 2024. These payments were reported across 353 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($7,666).
Ad
Practice Information
- Specialty Family
- Location Newport Beach, CA
- Active Since 09/28/2020
- Last Updated 12/05/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1770190340
Products in Payments
- OPDIVO (Biological) $457.77
- KISQALI (Drug) $397.13
- KEYTRUDA (Biological) $376.19
- REBLOZYL (Biological) $341.88
- Lenvima (Drug) $298.78
- TABRECTA (Drug) $272.15
- VERZENIO (Drug) $231.94
- MONJUVI (Drug) $217.84
- XPOVIO (Drug) $196.94
- Enhertu (Drug) $191.31
- Stivarga (Drug) $167.32
- AYVAKIT (Drug) $152.89
- JAKAFI (Drug) $152.46
- Xtandi (Drug) $147.99
- IBRANCE (Drug) $138.17
- DARZALEX (Biological) $135.81
- LYNPARZA (Drug) $112.27
- SCEMBLIX (Drug) $110.81
- ICLUSIG (Drug) $106.69
- OPDUALAG (Drug) $103.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Newport Beach
Carol Chow, Fnp-C, FNP-C
Family — Payments: $88,292
Family $88,292
Anisa Munshi, Dnp, DNP
Family — Payments: $62,040
Family $62,040
Mrs. Laura Conahan, Fnp, FNP
Family — Payments: $6,115
Family $6,115
Barret Bestard, Np, NP
Family — Payments: $4,514
Family $4,514
Aileen Slivkoff, Np, NP
Family — Payments: $4,283
Family $4,283
Elnaz Malekahmadi
Family — Payments: $4,058
Family $4,058